RILYZ vs TECH · rev $967.6M vs P/E 65, rev $1.22B
B. Riley Financial Inc. 5.25% Senior Notes due 2028 (RILYZ) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
B. Riley Financial Inc. 5.25% Senior Notes due 2028 (RILYZ) is a other company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RILYZ revenue for 2025-12-31 was $967.6M. Net income was $307.4M. Revenue was up 15.4% from 2024-12-31 to 2025-12-31. RILYZ currently screens at market cap $536.8M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RILYZ currently screens at market cap $536.8M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RILYZ and TECH stock pages for the full models.
Not investment advice.